James Rozsa Partner

Meet James

James is a corporate lawyer specialising in mergers and acquisitions, private equity transactions and equity capital markets.

He advises clients from a variety of industries including private equity sponsors. He is an expert in all aspects of domestic and cross-border M&A deals including public (takeovers and schemes of arrangements) and privately negotiated transactions and ECM deals including cross-border listings on the ASX.

James is qualified in both Australia and the US, and has for many years advised US clients doing business in Australia and Australian clients doing business in the US.

James has been consistently recognised by his peers (Best Lawyers) for each of M&A, Private Equity (2010-2019) and by his clients (Chambers) as a leading individual, again for each of Corporate/M&A, Private Equity (2011-2016) and Capital Markets (2016). In Chambers he is described as “easily the best private equity lawyer we have dealt with, especially on cross-border deals”and is regarded as a "solutions-based lawyer who is very hands-on during a deal" and is lauded for producing "high-quality work quickly and with strong client interaction.”

Experience

Private Equity M&A

APVC

Acting for Action Potential Venture Capital, a GSK fund, in Saluda Medical Series D financing round.

Exponent Private Equity

Acting for Exponent's portfolio company Big Bus in its acquisition of City Sightseeing.

Seven Group

Acting for Seven in various centure capital investments.

MH Carnegie

Acting for Carnegie in its investment in Renew Medical.

Archer Capital

Acting for Archer in connection with various bolt-on acquisitions for its flight services business Aero-Care.

Archer Capital

Acting in relation to Archer’s acquisition of Dun & Bradstreet’s Australian and New Zealand businesses.

AIM

Acting for the Australian Institute of Management in relation to CHAMP Venture’s investment into AIM’s training business.

Arboretum Ventures

Acting as Australian counsel for Arboretum Ventures, a Michigan-based venture capital firm specialising in the healthcare sector, in its participation in Cardiac Dimensions equity financing.

L Capital Asia

acting in relation to its investment in swimwear company Seafolly.

Archer Capital

Acting in relation to Archer’s secondary buy-out of mining services business LCR Group.

Calera Capital

Acting in relation to its acquisition of Transaction Services Group.

Canberra Data Centres

Acting for CDC and its shareholders in their partial divestment to Quadrant Private Equity.

Insight Venture Partners

Acting for Gettheworldmoving in its sale to Virgin Pulse, a portfolio company of Insight.

Insight Venture Partners

Acting for Insight in its investment in email marketing business Campaign Monitor.

Archer Capital

Acting in relation to Archer’s secondary buy-out of flight services business Aero-Care

L Capital Asia

Acting in relation to its investment in sports apparel company 2XU.

L Capital Asia

Acting in relation to itsacquisition of iconic Australian boot maker RM Williams.

Archer Capital

Acting in relation to Archer’s acquisition of Lend Lease’s Primelife Aged Care business.

Archer Capital

Acting in relation to Archer’s acquisition of the V8 Supercars business.

Virgin Active Australia

Acting for Virgin Active Australia and Virgin Group in the $1 billion divestment of 51% of the Virgin Active business to CVC.

Mergers & Acquisitions

Andean Resources (ASX:AND)

Acting in its $3.6 billion acquisition of GoldCorp Inc.

EnGeneIC Ltd

Acting for EnGeneIC in its redomicile by schemes of arrangement to Bermuda.

LiveOps Inc

Acting in its acquisition of all of the assets of Datasquirt Ltd (ASX:DSQ).

Peplin Inc (ASX:PLI)

Acting on its $300 million merger with LEO Pharma.

Presidian

Acting for Presidian (a specialist finance, warranty and motor insurance provider) and its shareholders in the sale of Presidian to McMillan Shakespeare Ltd (ASX:MMS).

Seven

Acting for Seven Group Holdings in its investment in iSeekplant.

SingTel’s Amobee

Acting as Australian counsel in relation to Amobee’s acquisition of Adconion.

Virgin Group

Acting in relation to Virgin’s sale of Virgin Money Australia to Bank of Queensland (ASX:BOQ).

Vocation Ltd (ASX:VET)

Acting in relation to VET’s acquisition of Endeavour Learning and Real Institute.

Vodafone Group

Acting on the A$8 billion merger with Hutchison, and advised in relation to the acquisition of Crazy John’s.

Equity Capital Markets

Visioneering Technologies, Inc (ASX:VTI)

acting for VTI on its Australian IPO and ASX-listing.

AirXpanders Inc (ASX:AXP)

Acting for AXP on its Australian IPO and ASX-listingand various fundraisings.

BSA Ltd (ASX:BSA)

Acting for BSA in its placement and underwritten pro-rata entitlement offer.

Energy World Corporation (ASX:EWC)

acting in relation to its PIPE by Standard Chartered Private Equity.

ImpediMed Ltd (ASX:IPD)

Acting for IPD in various fundraisings, including its underwritten pro-rata entitlement offer and placement.

Kai Medical Inc

Acting on its proposed IPO and ASX-listing.

Novo A/S

Acting as Australian counsel in its financing of Spinifex.

Osprey Medical Inc (ASX:OSP)

Acting for OSP in relation to various fundraisings.

Sunshine Heart (ASX:SHC)

Acting in relation to SHC’s concurrent private placement of CDIs and (as Australian counsel) its IPO and Nasdaq-listing.

Uptake Medical Inc

Acting on its proposed IPO and ASX-listing.

Vocation Ltd (ASX:VET)

Acting in relation to VET’s IPO and ASX-listing.

Recognition

Recommended in Corporate and M&A law
Asia Pacific Legal 500, 2018
Recommended in Capital Markets
Asia Pacific Legal 500, 2018
Ranked as a leading lawyer in Capital Markets, Corporate/M&A and Private Equity
Chambers Asia-Pacific, 2018
Listed as a leading lawyer in Private Equity, Mergers and Acquisitions and Equity Capital Markets Law
Best Lawyers Australia, 2019
James Rozsa is ... particularly valued by clients as an adviser with "the rare quality of assessing risk rather than just identifying it and focusing on the stuff that poses genuine problems."
Chambers Asia-Pacific, 2017
James Rozsa is highlighted for his "legal expertise and great professional advice," and also for his "great communication skills and management of investor expectations and concerns."
Chambers Asia-Pacific, 2015
James Rozsa is described as a "solutions-based lawyer who is very hands-on during a deal," and is also lauded for producing "high-quality work quickly and with strong client interaction."
Chambers Asia-Pacific, 2014
James Rozsa is praised by clients for his "tireless work on documentation" and for proving "good in both service and content."
Chambers Asia-Pacific, 2014

Career & qualifications

Qualifications

  • Bachelor of Laws, Sydney University
  • Bachelor of Arts, Sydney University
  • New York State Bar

International experience

  • Qualified in both Australia and the US, James has closed many deals around the world, including in Sydney, New York, London, Milan, Stockholm and Beijing.
  • James also has experience in North America and Europe as an investment banker.
  • James has for many years advised US clients doing business in Australia and Australian clients doing business in the US, including a number of US med-tech companies on their proposed Australian IPOs and ASX-listings.

 

Insights Read more insight

Australia’s media reform and its impact on M&A activity

On 16 October 2017, the Broadcasting Legislation Amendment (Broadcasting Reform) Bill 2017 (Cth) was passed by Australia’s House of Representatives and granted Royal assent. Following the Royal...

More
New FIRB Business Exemption Certificates

There are a number of associated issues and uncertainties regarding a new exemption certificate for business acquisitions by foreign investors (Business EC).

More
Transparency on the beneficial ownership of companies

In February 2017, the Australian Government released a consultation paper titled ‘Increasing Transparency of the Beneficial Ownership of Companies’ (Consultation Paper) to explore the potential to...

More